Летрозол Nucleus

Летрозол Nucleus (Letrozole) is an oral aromatase inhibitor used primarily in hormone receptor-positive breast cancer management. This EU-sourced medication helps reduce estrogen levels to slow tumor growth. Suitable for postmenopausal women, it is taken as directed by a healthcare provider.

Letrozole is commonly prescribed to treat hormone receptor-positive breast cancer in postmenopausal women. It works by lowering estrogen levels in the body, which can slow or stop the growth of certain breast cancers. This medication may also be used off-label for other estrogen-related conditions as determined by a physician.

Users may experience mild to moderate side effects such as hot flashes, joint pain, or fatigue. Some individuals report temporary changes in mood or sleep patterns. These effects vary by person and are typically manageable with medical guidance.

Store letrozole at room temperature away from moisture and heat. Keep out of reach of children and pets. Do not use if the packaging is damaged or the medication appears altered. Consult a healthcare professional before starting or stopping this medication.

Letrozole may interact with other medications, including certain antidepressants, hormone therapies, or drugs that affect liver enzymes. Alcohol and grapefruit products can also influence its effects. Always inform your doctor about all medications and supplements you are taking.